The Lancet Infectious Diseases – Published: January 30, 2018
Malaria remains one of the most preventable causes of adverse birth outcomes. Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine–pyrimethamine is used to prevent malaria, but resistance to this drug combination has decreased its efficacy and new alternatives are needed. Additionally, coverage of IPTp and insecticide treated nets continues to lag behind targets. The key barriers to uptake are well documented, and many are open to intervention. This Series of three reports brings readers up to date on the burden, pathology, costs, prevention, and treatment of uncomplicated and severe malaria during pregnancy.